share_log

Fate Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Boxer Capital, LLC(6.3%),Boxer Asser Management Inc.(6.3%), etc.

Fate Therapeutics | SC 13G:超过5%持股股东披露文件-Boxer Capital, LLC(6.3%),Boxer Asser Management Inc.(6.3%)等

美股sec公告 ·  02/12 18:10
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息